About Us
Homy FH China Patient Network was founded in April 2020. It initially served as a communication platform for the FH patient community, sharing research progress, treatment information, medical security policies, etc. with fellow patients; Respond to patients' actual needs through daily services for patients and hierarchical management.
Now committed to becoming a hub organization in the FH diagnosis and treatment ecosystem, providing fullcycle support for FH patients through data empowerment, diagnosis and treatment connection, and community support; Support research and accelerate clinical practice by initiating research funds, opening data, and collaborating on clinical research; Build an ecosystem platform through academic conferences, policy advocacy, and international exchanges.
Vision
Familial Hypercholesterolemia (FH) is no longer a threat to life.
Objectives
To promote early diagnosis and effective interventions, empowering FH patients to live free from cardiovascular disease.
Values
Patient-centered, guided by evidence-based medicine.
Jenna, ChenFounder of Homy FH China Patient Network
Ya-Ni WangAcademic Project Manager of Homy FH China Patient Network
Meng LiProject Manager of Homy FH China Patient Network
Yun SongResearcher of homy FH China Patient NetWork
Meng YuanDigital Media Operations Manager of Homy FH China Patient Network
Our focus
Advance research and support HoFH patients in accessing effective treatments to prevent cardiovascular events.
Advocate for screening policies and promote timely diagnosis, awareness, and proactive intervention for HeFH patients.
